Specialized expertise and comprehensive laboratory services to advance cardiovascular disease research and therapeutic development.
Comprehensive infectious disease testing for vaccines, antivirals & therapeutics with advanced diagnostics & regulatory-compliant support.
Comprehensive lab capabilities for metabolic disease research, including biomarkers, LC-MS/MS, immunoassays, and genomics for high-impact data.
Expert lab support for rare disease research with bioanalytical testing, biomarkers, and specialty assays to accelerate novel therapy development.
Providing advanced cell therapy bioanalysis with validated assays, regulatory expertise, and clinical trial support to accelerate development.
Expert immunology and inflammation support—custom assays, biomarker analysis, and validated solutions for clinical trials across therapeutic areas.
Neurology expertise for clinical trials - biomarker discovery, neuroinflammation profiling, PK/PD analysis, and custom assay development.
Providing specialized vaccine testing and bioanalysis with integrated services to support safety, efficacy, and global development.
We offer specialized gene therapy bioanalysis with validated assays, molecular expertise, and regulatory support to advance development.
Expert bioanalysis for biologics and gene and cell therapies, with trusted assays and regulatory-compliant data.
Extensive experience and scientific depth in oncology research, supporting the development of innovative cancer therapies across all phases of clinical trials.
Explore our biomarker solutions for clinical trials - supporting drug development, diagnostics, and personalized medicine strategies.
Accelerate clinical trials with custom assay development and validation -tailored solutions for biomarker, molecular, and immunoassay needs.
Reliable immunogenicity testing for clinical trials: ADA, Nab, & T-cell assays to assess immune response and support regulatory submissions.
Comprehensive PK/TK services for clinical trials: accurate drug absorption, distribution, metabolism, & toxicity profiling you can trust.
Accelerate biosimilar development with expert analytical support—comparability, characterization, and regulatory-ready data solutions.
Comprehensive gene expression assay solutions for clinical trials—accurate quantification, biomarker analysis, and transcriptomic insights.
Expert PBMC isolation services for clinical trials: high-quality cell separation, viability, & recovery for downstream immunological assays.
Advanced respiratory pathogen testing for clinical trials—accurate detection, quantification, and monitoring of viral and bacterial targets.
Delivering robust cell-based assay solutions for clinical trials—functional, potency, and mechanism-of-action testing tailored to your needs.
Comprehensive DNA/RNA analysis, biomarker discovery, and precision medicine insights for clinical trials.
End-to-end PCR solutions for clinical trials—conventional PCR, RT-qPCR, and ddPCR for sensitive, high-throughput nucleic acid detection and analysis.
High-quality sequencing assay services for clinical trials—NGS, targeted panels, and custom solutions for genomic, transcriptomic, and pathogen analysis.
Comprehensive cell culture services, including assay development, PBMC isolation, and support for preclinical and clinical studies.
Expert ligand binding and immunoassay services for biologics, vaccines, and biosimilars with validated ELISA, MSD, ECL, and multiplex platforms.
Advanced molecular testing using PCR, qPCR, & sequencing for sensitive detection & quantification to support clinical & preclinical studies.
High‑sensitivity ELISpot assays to measure antigen‑specific cellular immune responses for vaccine, immunology, & infectious disease studies.
State‑of‑the‑art instrumentation platforms delivering precise, high‑throughput biomarker analysis for clinical and preclinical studies.
End-to-end PCR solutions for clinical trials: PCR, RT-qPCR, & ddPCR for sensitive, high-throughput nucleic acid detection and analysis.
Multiparameter flow cytometry for detailed immune profiling, phenotyping, & biomarker analysis to support preclinical and clinical studies.
Cutting‑edge mass spectrometry workflows designed for challenging analytes, rigorous validation, and regulatory‑ready data.
Insights, industry trends, and scientific perspectives to help you navigate challenges in clinical development and biomarker testing.
Expert conversations on emerging science, clinical trial challenges, and innovations shaping the future of drug development.
On‑demand and live sessions featuring scientific experts discussing key topics in molecular testing, bioanalysis, and clinical trials.
Quick, easy‑to‑read overviews of our services, capabilities, and technical expertise to support your program planning.
Scientific posters from leading conferences highlighting our latest data, methods, and research contributions.
In‑depth technical papers exploring complex challenges, emerging technologies, and best practices in bioanalytical and molecular science.
Real‑world examples showcasing how our scientific strategy, technology, and partnership drive successful study outcomes.
Peer‑reviewed articles authored by our scientists, covering advanced methods, clinical insights, and breakthrough discoveries.
Specialized bioanalytical services – accurate, validated assays for drug development, biomarker analysis, and regulatory support.
End-to-end clinical trial supply solutions—packaging, labeling, storage, and global distribution of Investigational Medicinal Products (IMPs) and Advanced Therapy Medicinal Products (ATMPs).
Offering advanced bioinformatics services to transform complex data into actionable insights for drug development and precision medicine.
Collaborative pathology services for clinical trials—expertise in women’s health, urology, oncology, and integrated regulatory support.
Global central laboratory services—specialized testing, logistics, and data management to support Phase I–IV clinical trials with precision.
Specialty testing services for clinical trials—expert sample analysis, method transfer, assay development, and validation for reliable results.
Reliable data management for clinical trials—secure sample analysis, method transfer, assay development, validation, and regulatory compliance.
Secure sample management: traceable, temperature-controlled solutions with global logistics and long-term clinical trial support.
Expert project management for clinical trials—coordinating sample analysis, method transfer, assay development, validation, and timelines.
Robust quality systems and LIMS platforms ensure secure, compliant, and high-quality data for every phase of clinical trial research.
View in a different locale / language
Robust quality systems and LIMS platforms ensure secure, compliant, and high-quality data for every phase of clinical trial research.
GLP/GCP‑aligned, GCLP‑style quality systems deliver reliable, submission‑ready data end‑to‑end in our purpose‑built Lenexa facility.
GLP, GCP, and GCLP alignment. We operate under GLP/GCP and GCLP‑aligned quality frameworks, with independent QA oversight and documented processes built for regulatory review.
CLIA where applicable. Clinical testing in our network follows CLIA requirements, with additional state licensure as needed, supporting end‑to‑end clinical programs.
21 CFR Part 11 and 58. Electronic records and signatures comply with 21 CFR Part 11; our bioanalytical quality systems are based on 21 CFR Part 58, with internal audits, e‑documentation, training, deviation and CAPA programs, and SOPs.
ALCOA‑driven records. We maintain accountability and traceability through validated systems, documented controls, and QA review.
Chain of custody from receipt to result. Sample registration, labeling, storage/retrieval, and final disposition are fully traceable, preserving chain of custody across every hand‑off.
Facility designed for compliance. Our consolidated Lenexa facility was built to support regulated workflows and data integrity across modern clinical programs.
Defensible methods. Assays are developed, transferred, and validated per global guidance; our teams support fit‑for‑purpose validation with clear acceptance criteria and documentation.
Change control and CAPA. Formal deviation, change control, and CAPA programs ensure issues are captured, investigated, and closed with preventive actions.
Part 11‑compliant e‑systems. We manage training, documentation, and controlled records electronically to ensure version control and audit trails for all study‑critical activities.
Submission‑ready outputs. Reports and data packages are prepared to support inspections and regulatory submissions, streamlining sponsor pathways from Phase I to post‑market.
Audit‑ready operations grounded in GLP/GCP and GCLP‑aligned practices.
Electronic, Part 11‑compliant records with end‑to‑end traceability.
Documented chain of custody across registration, storage, and final disposition.
Independent QA oversight with internal audits, deviation/CAPA, and SOP control.
Facility built for compliance and modern clinical trial demands.
Global process harmonization to support multi‑site, multi‑country trials.
Discover how biopharma teams ensure compliance across preclinical and clinical stages through GLP, GCP, and GCLP standards.
Ready to evaluate your program against our quality framework – or need an audit‑ready plan for a fast‑moving study? Contact our experts to align standards, documentation, and timelines with your clinical objectives.